Xanthon

Xanthon was a life science tools company that developed a proprietary electrochemical detection platform for the analysis of DNA and RNA. The company's technology enabled the direct electronic detection of nucleic acid hybridization, offering a faster and more cost-effective alternative to traditional fluorescence-based methods. Its primary product, the Xanthon X-Ray System, was designed for applications in gene expression profiling and molecular diagnostics. The platform eliminated the need for complex labeling and optical detection systems, streamlining laboratory workflows. In 2002, the company was acquired by Evotec OAI to enhance its drug discovery service offerings with advanced detection capabilities.